Javascript must be enabled to continue!
The effect of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder
View through CrossRef
Abstract
Background
Men with overactive bladder (OAB) and benign prostatic hyperplasia (BPH), will have deterioration in the quality of life.
Objective
The aim of this study was to evaluate the effect of combining pelvic floor muscle training with the urgency suppression technique (PFMT-st) and silodosin in comparison with silodosin in men with benign prostatic hyperplasia (BPH) and overactive bladder (OAB) after 12 weeks of treatment.
Patients and methods
A total of 158 patients were randomized into two groups. The control group received oral silodosin at a daily dose of 8 mg. The experimental group was administered PFMT-st and silodosin. The evaluation methods included the number of voids and intensity of urgencies over 24 h using a micturition diary, the International Prostate Symptom Score (IPSS), the Overactive Bladder Questionnaire (OAB-q), and the patient global impression of improvement (PGI-I).
Results
142 of 172 (86.6%) men were assessed (70 in the control group, 72 in the experimental group). The significant changes were in favor of the experimental group (p < 0.001) in the number of voids per 24 h (− 1.95 ± 1.94 vs. − 0.90 ± 1.44), the OAB-q symptom score (− 14.25 ± 10.05 vs. − 9.28 ± 10.60), the intensity of urgencies (− 0.97 ± 0.53 vs. 0.24 ± 0.57), the IPSS (− 4.59 ± 3.00 vs. − 2.30 ± 3.63), and in the PGI-I (2.24 ± 0.79 vs. 3.60 ± 0.92).
Conclusions
The addition of PFMT-st to silodosin treatment significantly improved OAB in men with BPH. This is the first study to confirm that PFMT-st should be the first-choice treatment for OAB in BPH.
Springer Science and Business Media LLC
Title: The effect of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder
Description:
Abstract
Background
Men with overactive bladder (OAB) and benign prostatic hyperplasia (BPH), will have deterioration in the quality of life.
Objective
The aim of this study was to evaluate the effect of combining pelvic floor muscle training with the urgency suppression technique (PFMT-st) and silodosin in comparison with silodosin in men with benign prostatic hyperplasia (BPH) and overactive bladder (OAB) after 12 weeks of treatment.
Patients and methods
A total of 158 patients were randomized into two groups.
The control group received oral silodosin at a daily dose of 8 mg.
The experimental group was administered PFMT-st and silodosin.
The evaluation methods included the number of voids and intensity of urgencies over 24 h using a micturition diary, the International Prostate Symptom Score (IPSS), the Overactive Bladder Questionnaire (OAB-q), and the patient global impression of improvement (PGI-I).
Results
142 of 172 (86.
6%) men were assessed (70 in the control group, 72 in the experimental group).
The significant changes were in favor of the experimental group (p < 0.
001) in the number of voids per 24 h (− 1.
95 ± 1.
94 vs.
− 0.
90 ± 1.
44), the OAB-q symptom score (− 14.
25 ± 10.
05 vs.
− 9.
28 ± 10.
60), the intensity of urgencies (− 0.
97 ± 0.
53 vs.
0.
24 ± 0.
57), the IPSS (− 4.
59 ± 3.
00 vs.
− 2.
30 ± 3.
63), and in the PGI-I (2.
24 ± 0.
79 vs.
3.
60 ± 0.
92).
Conclusions
The addition of PFMT-st to silodosin treatment significantly improved OAB in men with BPH.
This is the first study to confirm that PFMT-st should be the first-choice treatment for OAB in BPH.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
Background: Benign prostatic hyperplasia [BPH] is the urologic condition that affects elderly men the most frequently Benign prostatic hyperplasia. Benign prostatic hyperplasia mus...
(087) Why Should Pelvic Floor Physical Therapy be Included in Treatment of Vestibulodynia?
(087) Why Should Pelvic Floor Physical Therapy be Included in Treatment of Vestibulodynia?
Abstract
Introduction
Vestibulodynia, vulvar pain localized to the vestibule without an identifiable cause, has a multifactorial...
The Muscle Cells in Pelvic Floor Dysfunctions: Systematic Review
The Muscle Cells in Pelvic Floor Dysfunctions: Systematic Review
Background/Aims: The pelvic floor muscles are important structures involved in pelvic floor tone, pelvic organ support, and continence. The aim of this study was to perform an upda...
The Medical Rehabilitation of Overactive Bladder after Transurethral Resection of the Prostate: A Case Report
The Medical Rehabilitation of Overactive Bladder after Transurethral Resection of the Prostate: A Case Report
Introduction: Overactive bladder is a syndrome of increased urinary frequency and nocturia with or without incontinence in absence of obvious pathology. Transcutaneous Tibial Nerve...
Types of the prostate blood supply during super-selective embolization of prostatic arteries
Types of the prostate blood supply during super-selective embolization of prostatic arteries
Introduction. Pelvic arteries have various anatomy and anastomoses with other branches of the internal iliac artery (IIA). This explains the technical complexity of identification ...
Prostate specific antigen in the serum of men ≥ 50 years old with benign prostatic hyperplasia and some related factors
Prostate specific antigen in the serum of men ≥ 50 years old with benign prostatic hyperplasia and some related factors
Background: Men over 50 years old often have lower urinary tract symptoms and most of them are caused by benign prostatic hyperplasia (BPH). The incidence of benign prostatic hyper...
The Efficacy of Tamsulosin Monotherapy and Its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Hyperplasia
The Efficacy of Tamsulosin Monotherapy and Its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Hyperplasia
Abstract
Background
Alpha 1 adrenoceptor antagonists such as (tamsulosin) are developed for treating of overactive bladder (OAB)...

